Background-Noninvasive methods for characterizing neovessel formation during angiogenesis are currently lacking. We hypothesized that angiogenesis could be imaged with the use of contrast-enhanced ultrasound (CEU) with microbubbles targeted to ␣ v -integrins. Methods and Results-Microbubbles targeted to ␣ v -integrins were prepared by conjugating echistatin (MB E ) or monoclonal antibody against murine ␣ v (MB ␣ ) to their surface. Control microbubbles (MB c ) were also prepared. The microvascular behavior of these microbubbles was assessed by intravital microscopy of the cremaster muscle in mice treated for 4 days with sustained-release FGF-2. Microvascular retention was much greater (PϽ0.01) for MB E (11Ϯ6 mm
T
here is currently great interest in either promoting angiogenesis in chronically ischemic tissue or arresting angiogenesis in neoplasms or diabetic retinopathy. A noninvasive technique capable of temporally assessing neovessel formation with high resolution would be desirable for assessing these processes. In this study, we examined whether microbubbles targeted to endothelial cell receptors could be used to assess angiogenesis. This strategy is based on our previous experience with contrast-enhanced ultrasound (CEU) and site-targeted microbubble agents that are retained in regions of disease by virtue of their shell properties or by conjugation of specific ligands to their surface. The ability to noninvasively assess inflammatory responses in vivo by using CEU has been demonstrated with the use of microbubbles targeted activated leukocytes 1, 2 or to endothelial cell adhesion molecules. 3 We hypothesized that CEU with microbubbles targeted to ␣ v -integrins expressed on neovascular endothelium 4, 5 could be used to assess early angiogenesis noninvasively. Lipid microbubbles were targeted by surface conjugation of monoclonal antibody (mAb) or an RGD-containing peptide with a high affinity for ␣ v -integrins. Retention of these agents in growth factor-stimulated vessels was assessed by intravital microscopy in the mouse cremaster muscle. The ability of CEU to image microbubbles retained in angiogenic vessels was also assessed in growth factor-enriched subcutaneous matrigel plugs in mice.
Methods

Microbubble Preparation
Two microbubble agents targeted to ␣ v integrins were constructed bearing either mAbs against the integrin ␣ v chain (MB ␣ ) or the RGD-containing disintegrin echistatin (MB E ). Control microbubbles bearing isotype control mAb (MB c ) were also constructed. First, biotinylated lipid-shelled microbubbles containing decafluorobutane gas were prepared. 6 Either 2.5 g of biotinylated echistatin (Sigma), 75 g of biotinylated rat anti-mouse monoclonal IgG 1 against ␣ v -integrins (RMV-7), or isotype control antibody (R3-34, Pharmingen Inc) were conjugated to their surface. 3 For intravital microscopy studies, microbubbles were fluorescently labeled with dioctadecyl-oxacarbocyanine (Molecular Probes). For perfusion imaging, nontargeted lipid-shelled microbubbles (MP1950) were also prepared. 1 Microbubble concentration and size distribution were determined by electrozone sensing with a Coulter Multisizer IIe (Beckman-Coulter).
In Vitro Integrin Expression of Murine Endothelial Cells
Study protocols were approved by the Animal Research Committee at the University of Virginia. Expression of ␣ v -integrins in response to FGF-2 was tested by immunofluorescent microscopy of cultured murine endothelial cells prepared from the thoracic aorta of mice, as previously described. 7 Confluent cells were stimulated by 50 ng/mL of FGF-2 for 48 hours. Plates containing stimulated or control cells were incubated with the mAb RMV-7 for 10 minutes, washed, then incubated with phycoerythrin-labeled goat anti-rat secondary antibody (Pharmingen Inc) for 10 minutes. Separate cells were also incubated with the fluorescent secondary antibody alone to exclude nonspecific cellular interactions. Fluorescent microscopy (excitation filter 530 to 560 nm) of washed cells was performed with the use of a microscope (Axioskop2-FS, Carl Zeiss, Inc) and a high-sensitivity silicone-intensified tube camera (SIT68, Dage-MTI).
FGF-2 Stimulation of Cremaster Microvessels
Heparin-agarose beads (10 mg/mL) were mixed with calcium alginate (1.2% wt/vol), and the slurry was dropped through a 25-gauge needle into a 1.5% CaCl 2 hardening solution to form 400-to 600-m microcapsules. Fifteen microcapsules were combined with 1 g FGF-2 for 24 hours to create a controlled release platform. 8, 9 Intrascrotal implantation of FGF-2-containing (nϭ6) or control (nϭ4) pellets was performed by aseptic technique in 10 wild-type C57Bl/6 mice (Jackson Laboratory, Bar Harbor, Maine). Pellets were "reloaded" once daily for 4 days with supplemental intrascrotal injections of either FGF-2 (125 ng) or saline for control mice.
Microvascular Behavior of Targeted Microbubbles
Intravital microscopy of the cremaster muscle was performed 4 days after pellet implantation to assess the microvascular behavior of targeted and control microbubbles. Animals were anesthetized with an intraperitoneal injection (12.5 L/g) of a solution containing ketamine hydrochloride (10 mg/mL), xylazine (1 mg/mL), and atropine (0.02 mg/mL). A jugular vein was cannulated for administration of microbubbles and the cremaster muscle was exteriorized and fixed to a microscopy stage. Observations were made with the use of an Axioskop2-FS microscope (Carl Zeiss, Inc) with a saline-immersion objective (SW 40/0.8 numerical aperture). Video recordings were made with a high-resolution CCD camera (C2400, Hamamatsu Photonics) connected to an S-VHS recorder (S9500, JVC).
Microbubble behavior was assessed by fluorescent epiillumination with a 460-to 500-nm excitation filter. Twenty optical fields (total tissue volume 4.2ϫ10 Ϫ3 cm 3 ) 10 were recorded 5 minutes after injection of 1ϫ10 7 fluorescently labeled MB c , MB ␣ , or MB E microbubbles in random order. Vascular density was assessed by fluorescent epi-illumination after intravenous injection of 5 g FITC-dextran-70 in 4 mice in each group. Cumulative linear density was measured by calibrated video calipers in 4 optical fields (ϫ20), and data were averaged for vessels with diameters of Յ10 m, 10 to 20 m, and Ͼ20 m.
Matrigel Model of Angiogenesis
Subcutaneous matrigel plugs were created in 12 wild-type C57BL6 mice to promote neovessel formation. 11 Matrigel (Collaborative Biomedical), a tumor basement membrane matrix extract, was thawed at 4°C and enriched with heparin (64 U/mL) and FGF-2 (500 ng/mL). Mice were anesthetized and 1 mL of enriched Matrigel (4°C) was injected subcutaneously in the left ventral region. Matrigel hardened to form discrete ellipsoid plugs.
Fluorescent confocal microscopy was performed in 3 mice to characterize microbubble retention in matrigel plugs. Ten days after matrigel injection, either MB c , MB ␣ , or MB E microbubbles (1ϫ10 7 ) labeled with dioctadecyl-tetramethylindocarbocyanine (Molecular Probes) were injected intravenously. After 15 minutes, vascular staining was performed with intra-arterial injection of 1 mg fluorescein Lycopersicon esculentum lectin. 12 Perfusion fixation was performed with 4% paraformaldehyde in PBS, and thick sections of matrigel were examined with the use of a confocal laser scanning microscope (LSM510, Carl Zeiss Inc), using dual fluorescence overlays.
Contrast-Enhanced Ultrasound
CEU of matrigel plugs was performed in 9 anesthetized mice 10 days after matrigel injection. Imaging was performed with a Sonos 5500 system (Philips Ultrasound), with harmonic power Doppler imaging at a transmit frequency of 1.6 MHz and a mechanical index of 1.0, with a small water bath serving as an acoustic interface. The acoustic focus was placed at the mid-level of the matrigel. Gain settings, compression, and pulse repetition frequency settings were optimized and held constant. Data were recorded on a magnetic optical disk and transferred to a computer for off-line analysis.
CEU imaging was performed after intravenous injection of 5ϫ10 6 MB c , MB ␣ , or MB E in random order at 20-minute intervals. Imaging was initiated 15 minutes after each injection to allow microbubble retention and clearance of most circulating microbubbles from the blood pool. 1, 3 The signal from the initial frame represented both retained and freely circulating microbubbles. 1, 3 After destruction of these microbubbles by 2 to 3 seconds of continuous imaging, intermittent imaging at a pulsing interval (PI) of 10 seconds was performed to derive the signal only from freely circulating microbubbles. 13 These frames were averaged and digitally subtracted from the initial frame to create a single image representing only retained microbubbles. Background-subtracted acoustic intensity (AI) was measured from this image. 14 Perfusion imaging of the matrigel plug was also performed with an infusion of nontargeted MP1950 microbubbles (5ϫ10 6 per minute). Background images were acquired during continuous imaging at 30 Hz, and intermittent imaging was performed with progressive prolongation of the PI from 200 ms to 20 seconds. Averaged background frames were digitally subtracted from averaged frames at each PI, and the acoustic intensity was measured within specified regions of interest. PI versus acoustic intensity data were fit to the function, yϭA (1Ϫe Ϫ␤t ), where y is AI at the PI t, A is plateau video intensity (an index of blood volume), and ␤ is the rate constant that provides a measure of microvascular red blood cell (RBC) velocity. 13 Color-coding for visual analysis was performed on a pixel basis Figure 1 . A, Fluorescent microscopy images of control and FGF-2-treated murine endothelial cells exposed to primary and fluorescent secondary mAb, (1°ϩ2°) or secondary mAb alone (2°). B, Intravital microscopy of the microcirculation of the cremaster muscles after intravenous administration of FITC-dextran in a control and FGF-2-treated mouse. Scale barϭ25 m.
by assigning a color from a scale expanded to 256 levels, based on background-subtracted AI. 14 
Histopathology and Immunohistochemistry
Paraffin-embedded matrigel sections were stained with hematoxylin and eosin. Immunostaining for ␣ v -integrins was performed on frozen sections of matrigel. Affinity-purified rat mAb against murine ␣ v -integrins (RMV-7, Pharmingen Inc) was used as a primary antibody followed by a biotinylated goat anti-rat secondary antibody (Vector Laboratories). Staining was performed with a peroxidase kit (ABC Vectastain Elite, Vector Laboratories) and 3,3Ј-diaminobenzidine chromagen (DAKO). Slides were counterstained with hematoxylin.
Statistical Methods
Data are expressed as meanϮSD. Comparisons between groups was performed with ANOVA. When differences were found, comparisons between two groups were performed by means of a nonpaired Student's t test with Bonferroni correction. Correlations were performed by means of least-squares-fit linear regression analysis. Differences were considered significant at PϽ0.05 (2-sided).
Results
Microbubble Retention in the Cremaster Microcirculation
Expression of ␣ v -integrins by murine endothelial cells in vitro after exposure to FGF-2 for 48 hours was detected by immunofluorescent microscopy ( Figure 1A ). Intravital microscopy images of the microcirculation of the cremaster muscle of mice receiving control or FGF-2-eluting alginate pellets are shown in Figure 1B . In FGF-2-treated mice, focal regions of increased vascular density were observed, characterized by tortuous, poorly defined microvessels. Abnormal vascular permeability was seen in these areas, manifest by extravascular blush of FITC-dextran. The linear density of vessels was greater for microvessels Յ10 m in diameter for FGF-2-treated compared with control mice (Table) .
In mice receiving control pellets, microbubble retention in the cremaster microcirculation was uncommon for all 3 agents (Figure 2A) . Most of this infrequent retention was from microbubble attachment to activated leukocytes adherent to the venular endothelium at sites of surgical trauma. In FGF-2-treated animals, retention of MB ␣ and MB E was substantially greater than in control animals, whereas retention of MB c tended to decrease with FGF-2 treatment (Figure 2A ). Enhanced retention of MB ␣ and MB E microbubbles in FGF-2-treated mice was almost entirely due to their attachment directly to the microvascular endothelial surface, with a slight preference toward small (Ͻ30 m) arterioles ( Figure 2B ), although attachment was also seen in small venules and capillaries (Ͻ10 m). Flux of RBCs around microbubbles retained in capillaries was frequently observed, indicating endothelial attachment rather than sizedependent entrapment. Direct endothelial attachment was not observed for MB c .
CEU Assessment of Matrigel Angiogenesis
Neovessel formation in the matrigel plugs was observed on histology in all 9 mice ( Figure 3A) , with a central region devoid of angiogenic vessels present in most. Intravascular RBCs were seen, indicating the presence of flow in these vessels. Vessel diameter ranged from 5 to 150 m, and both their size and density tended to increase with distance from the center. Immunohistochemistry demonstrated ␣ v -integrin expression on the endothelial surface of these vessels, the density of which greatest at the outer one-third margin of the plug ( Figure 3B ). Leukocytes were occasionally found in the matrigel and also stained for the ␣ v -integrin subunit. Illustrated in Figure 4 are representative CEU images and the corresponding PI versus AI curve from a matrigel plug during continuous infusion of nontargeted microbubbles. Progressive prolongation of the PI resulted in an incremental increase in AI until plateau was reached. Microvascular blood volume, represented by the image at the longest PI or quantitatively as the plateau AI, 13 tended to be greatest at the peripheral margins of the matrigel and was absent at the center of plugs that were determined by histology to have an avascular core. The size of the avascular region varied between 0% and 25% of the total area.
Cumulative Linear Density of Microvessels in the Cremaster Muscle in Control and FGF-2-treated Mice
Confocal microscopy revealed a poorly organized vascular network within the matrigel plug ( Figure 5 ). Retention of fluorescently labeled targeted but not control microbubbles was observed on dual fluorescence imaging ( Figure 5 ). On CEU imaging, the signal from retained microbubbles retained in matrigel 15 minutes after their intravenous administration was significantly greater for MB ␣ and MB E compared with MB c (Figure 6 ). Regions with the highest MB ␣ and MB E signal tended to correlate spatially with regions with the greatest microvascular blood volume seen on perfusion imaging. The backgroundsubtracted signal obtained during intermittent imaging at a PI of 10 seconds was low for all microbubble agents (MB c ϭ2.6Ϯ1.4, MB ␣ ϭ2.9Ϯ2.0, MB E ϭ3.0Ϯ1.5 U), indicating the presence of few freely circulating microbubbles at 15 minutes.
The signal intensity for retained MB ␣ and MB E correlated well with the matrigel microvascular blood volume (A value of the PI versus AI curves) irrespective of whether analysis was performed for the entire matrigel plug or excluding nonperfused areas (regions where microbubble signal was absent on perfusion imaging) from analysis ( Figure 7) . The signal from retained microbubbles did not correlate with microvascular blood velocity (␤ value of the PI versus AI curves).
Discussion
In the present study, we have demonstrated for the first time that angiogenesis can be characterized in vivo by using CEU and microbubble contrast agents targeted to endothelial cell surface receptors expressed in neovessels. Targeted microbubbles were created by conjugation of either mAbs or peptide ligands for ␣ v -integrins to their surface. Both ␣ v ␤ 3 and ␣ v ␤ 5 are differentially expressed in tumor and developmental models of angiogenesis, and ␣ v ␤ 3 in particular appears to play a functional role in neovessel formation. 6, 7, 15 The ability of ␣ v ␤ 3 to bind to many of the components of the extracellular matrix contributes to cell migration, adhesion, and differentiation during vasculogenesis or angiogenesis. This binding relies largely on integrin recognition of the RGD peptide sequence, which was the basis for microbubble targeting with the use of echistatin, a peptide that contains an RGD sequence in a mobile loop. 16 This disintegrin was chosen because of its relative affinity to ␣ v ␤ 3 over nonactivated ␣ IIb ␤ 3 or the fibronectin receptor ␣ 5 ␤ 1 . 16, 17 In growth factor-stimulated cremaster muscles and subcutaneous matrigel plugs, targeting efficiency was equivalent for echistatin and ␣ v -specific mAb strategies. Advantages of using short peptides for targeting in the clinical setting include less immunogenicity, lower cost, and problems with antibody availability.
Microbubble targeting was tested in models designed to mimic vascular responses to FGF-2, one of several proangiogenic factors under clinical investigation for treatment of ischemia. Although controlled-release FGF-2 treatment of the cremaster was performed only to stimulate endothelial ␣ v ␤ 3 expression, focal regions consistent with early angiogenesis were observed. Longer duration of treatment was not possible because of the hyperplastic and matrix responses that preclude videomicroscopy. Similar to previous descriptions, subcutaneous injection of FGF-2-enriched matrigel, composed of basement membrane proteins from murine Engelbreth-Holm-Swarm tumor, resulted in de novo vessel formation and penetration of neovessels. Expression of ␣ v ␤ 3 was confirmed by immunohistochemistry and has been shown to be a requirement for matrigel angiogenesis. 18 Enhanced retention of targeted microbubbles in these models was demonstrated by both microscopy and CEU. Retention of MB E and MB ␣ varied considerably, in part because of lower signal for the second targeted agent administered, implying competitive inhibition from residual free ligand. In the matrigel model there was also substantial variability in the degree of angiogenesis. Intravital microscopy confirmed direct attachment of targeted microbubbles to the endothelium rather than other potential mechanisms such as bubble accumulation in regions of abnormal perfusion or shear. Microbubble attachment occurred in small microvessels, with a slight preference toward small arterioles, where ␣ v ␤ 3 expression is likely to be high as the result of its putative role in extracellular matrix remodeling and endothelial cell invasion. 19 Occasional attachment of microbubbles to activated leukocytes was also observed. This process is mediated primarily by serum complement for microbubbles with shells composed of lipid. 20 Retention of nontargeted microbubbles was reduced by FGF-2, in accord with previous reports that FGF-2 can inhibit leukocyte recruitment in venules. 21 Yet the presence of leukocytes on matrigel histology indicated that microbubble-leukocyte interaction was still most likely responsible for the low-intensity ultrasound signal for control microbubbles.
The ultrasound imaging protocol used to detect retention of targeted microbubbles in matrigel neovessels has been used previously to image tissue inflammation with microbubbles targeted to activated leukocytes or endothelial P-selectin. [1] [2] [3] By imaging late after a single intravenous injection of contrast, signal from retained microbubbles relative to that of freely circulating microbubbles is optimized because of gradual removal of the latter from the blood pool. In the present study, the signal from freely circulating microbubbles 15 minutes after injection was very low, accounting for Ͻ15% of the contrast signal intensity on initial frames with the targeted agents. Ultrasound was performed with a high acoustic power, or mechanical index, to generate sufficient signal from retained microbubbles, which are susceptible to damping from cellular attachment. 22 Harmonic power Doppler processing was chosen because of its enhanced sensitivity for detecting microbubbles in tissue. In the future, quantification of angiogenesis in physiological models with targeted CEU probably will require other image processing methods that have a greater dynamic range and are more reliable in terms of the relation between microbubble concentration and acoustic intensity. Nonetheless, we found a good relation between the signal from ␣ v -targeted microbubbles and neovessel blood volume in matrigel.
There are several limitations of this study. First, it cannot be assumed that the models we used to test the feasibility of angiogenesis-targeted microbubbles are identical to diseaserelated angiogenesis in the clinical setting. On a more practical level, precise spatial correlation between CEU and immunohistology was not possible. This limitation was due to the difficulty spatially matching the ultrasound plane with matrigel sections that distorted after explantation and because 2-dimensional ultrasound images are formed from signals received over a beam elevation of several millimeters. Studies in physiological models of ischemic disease will be needed to address the question of whether this technique can image ␣ v -integrin expression that occurs in large vessels during arteriogenesis or in small microvessels. Finally, although prior studies have indicated that very few retained microbubbles are required to produce an easily detectable CEU signal, 22 the overall sensitivity for detecting angiogenesis with ␣ v -targeted microbubbles remains unknown.
Our results suggest that imaging microvascular phenotype with CEU can provide additional information by evaluating early response to growth factor stimulation in terms of spatial extent and amount of angiogenesis. Such information is likely to be very useful for guiding focal delivery of proangiogenic proteins or genes that require direct administration into ischemic tissue. In this setting, CEU signal from targeted microbubbles is likely to precede neovascularization since ␣ v -integrin expression may occur in preexisting vessels. Imaging angiogenic phenotype may also be useful for tumor detection and for providing information on prognosis, metastatic potential, or susceptibility to therapy. This has prompted early investigation into methods for detecting angiogenic phenotype with novel contrast agents used with MRI and positron emission tomography. [23] [24] [25] Since acoustic destruction of "payload-bearing" microbubbles can be used to focally deliver therapeutic drugs or augment gene transfection, 26 we believe that the role of angiogenesis-targeted microbubbles may uniquely extend beyond imaging and into the realm of site-specific therapy for ischemic tissues or tumors. Further characterization of ␣ v -targeted microbubbles in physiological models of ischemic or tumor angiogenesis will be necessary to explore these potential applications.
